Thomasville National Bank Bio Line Rx Ltd. Transaction History

Thomasville National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 02, 2021	BUY	$2.63 - $4.88 $26,300 - $48,800	10,000 New	10,000 $28,000
Q1 2021 Apr 01, 2021	SELL	$2.38 - $4.0 $48,373 - $81,300	-20,325 Closed	0 $0
Q4 2020 Jan 04, 2021	BUY	$1.47 - $3.62 $11,502 - $28,326	7,825 Added 62.6%	20,325 $51,000
Q3 2020 Oct 01, 2020	BUY	$1.56 - $2.37 $19,500 - $29,625	12,500 New	12,500 $21,000

3.3M

46.5K

6.3K

Ticker BLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,524,500
Market Cap $29.5M
Description
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...

Get notified when there are updates to the investment portfolio of Thomasville National Bank, based on Form 13F filings with the SEC.

Stay updated on Thomasville National Bank with notifications on news.